Posts tagged “LabCorp”
The Burlington-based company's latest deal - $241 million for Medtox Scientific - is just the latest in a series of acquisitions made over the past three years.
Burlington-based LabCorp will work with XDx to develop a biomarker and commercialize a test for the flares -- extended periods of activity for the autoimmune disease. Lupus causes the body's immune system to attack its own tissues, which leads to inflammation and organ damage.
Alzheimer's disease affects more than five million people in the United States and more than 35 million worldwide. There are no specific tests available to detect Alzheimer's disease and track its progression. Diagnosis is currently conducted by behavioral and cognitive measurements.
Laboratory testing and diagnostics firm LabCorp has secured the greater than 90 percent of shares in Orchid that allowed the company to proceed with a short-form merger, meaning the deal could go through without a shareholders meeting.
There is no shortage of companies angling for financial backing of new therapies and diagnostics in personalized medicine. But will challenges of regulations, reimbursements, costs and technical requirements be overcome?
Senators ask the company to provide information about discounted or below cost lab services offered to managed care organizations and payers in exchange for referrals of other laboratory testing business to LabCorp.
- US adds a robust 295K jobs; jobless rate falls to 5.5 percent
- 'Biosimilar' breakthrough: FDA approves first lower-cost biotech drug
- Apple will replace AT&T in the Dow Jones industrial average
- US trade deficit in January falls 8.3 percent to $41.8 billion
- Silicon Valley gender bias suit puts spotlight on venture capital industry